NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Euphrates Vascular

Euphrates Vascular

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://euphratesvascular.com/

Last Round

Series B

Oct 3, 2023

Total Funding Raised

$17.34M

Company Overview

Euphrates Vascular is a medical device company that develops and commercializes nanotechnology-based treatments for vascular occlusions, including Acute Ischemic Stroke, Peripheral Artery Disease, and ST-Elevated Myocardial Infarction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicevascular occlusionnanotechnologyinterventional cardiologyacute ischemic strokeAISperipheral artery diseasePADSTEMIthrombectomyminimally invasive surgeryreperfusion therapyneurovascular careinterventional radiologymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Euphrates Vascular Comps

Public and private peers based on sector, stage, and business model.

Euphrates Vascular comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Euphrates Vascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 3, 2023
GrantSep 1, 2022
GrantNov 20, 2018
GrantSep 1, 2016
VC RoundJan 26, 2016
VC Round
Apr 10, 2015

Euphrates Vascular Investors

Notable investors and investment history

Euphrates Vascular investors
InvestorRounds
NIH RADxGrant
FTL Capital LLCVC Round
Cultivation CapitalVC Round
Missouri Technology CorporationVC Round, Seed
+ND CapitalVC Round
St. Louis Arch AngelsVC Round
BioGenerator VenturesSeed, Series A

Euphrates Vascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Euphrates Vascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Euphrates Vascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range9
Year Founded2008
Last FundingOct 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.